Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob A Canick

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Clinics in Laboratory Medicine|July 10, 2003
Prenatal screening for Down syndrome: current and future methodsJacob A Canick, Devereux N Saller, Geralyn M Lambert-Messerlian
Advances in Clinical Chemistry|January 26, 2007
A summary analysis of Down syndrome markers in the late first trimesterGlenn E Palomaki, Geralyn M Lambert-Messerlian, Jacob A Canick
Prenatal Diagnosis|April 12, 2011
Impact of smoking on maternal serum markers and prenatal screening in the first and second trimestersJing Zhang, Geralyn Lambert-Messerlian, Glenn E Palomaki, et al.
Prenatal Diagnosis|January 6, 2011
Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetesNicole Sprawka, Geralyn Lambert-Messerlian, Glenn E Palomaki, et al.
Prenatal Diagnosis|September 30, 2005
Apparently low maternal serum inhibin A levels in second-trimester screeningGeralyn M Lambert-Messerlian, David F Keren, Constantine S Raphtis, et al.
Archives of Pathology & Laboratory Medicine|November 4, 2010
Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndromeGlenn E Palomaki, George J Knight, Geralyn Lambert-Messerlian, et al.
Prenatal Diagnosis|April 18, 2013
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidiesJacob A Canick, Glenn E Palomaki, Edward M Kloza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 20, 2009
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurementsGlenn E Palomaki, Jo Ellen S Lee, Jacob A Canick, et al.
Journal of the Society for Gynecologic Investigation|October 18, 2002
Mechanism of increased maternal serum total activin a and inhibin a in preeclampsiaHelayne M Silver, Geralyn M Lambert-Messerlian, Fernando M Reis, et al.
Journal of the Society for Gynecologic Investigation|May 22, 2003
Concentrations of serum total activin A and inhibin A in preterm and term labor patients: a cross-sectional studyMichael P Plevyak, Geralyn M Lambert-Messerlian, Antonio Farina, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Clinics in Laboratory Medicine|July 10, 2003
Prenatal screening for Down syndrome: current and future methodsJacob A Canick, Devereux N Saller, Geralyn M Lambert-Messerlian
Advances in Clinical Chemistry|January 26, 2007
A summary analysis of Down syndrome markers in the late first trimesterGlenn E Palomaki, Geralyn M Lambert-Messerlian, Jacob A Canick
Prenatal Diagnosis|April 12, 2011
Impact of smoking on maternal serum markers and prenatal screening in the first and second trimestersJing Zhang, Geralyn Lambert-Messerlian, Glenn E Palomaki, et al.
Prenatal Diagnosis|January 6, 2011
Adjustment of maternal serum alpha-fetoprotein levels in women with pregestational diabetesNicole Sprawka, Geralyn Lambert-Messerlian, Glenn E Palomaki, et al.
Prenatal Diagnosis|September 30, 2005
Apparently low maternal serum inhibin A levels in second-trimester screeningGeralyn M Lambert-Messerlian, David F Keren, Constantine S Raphtis, et al.
Archives of Pathology & Laboratory Medicine|November 4, 2010
Four years' experience with an interlaboratory comparison program involving first-trimester markers of Down syndromeGlenn E Palomaki, George J Knight, Geralyn Lambert-Messerlian, et al.
Prenatal Diagnosis|April 18, 2013
The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidiesJacob A Canick, Glenn E Palomaki, Edward M Kloza, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 20, 2009
Technical standards and guidelines: prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurementsGlenn E Palomaki, Jo Ellen S Lee, Jacob A Canick, et al.
Journal of the Society for Gynecologic Investigation|October 18, 2002
Mechanism of increased maternal serum total activin a and inhibin a in preeclampsiaHelayne M Silver, Geralyn M Lambert-Messerlian, Fernando M Reis, et al.
Journal of the Society for Gynecologic Investigation|May 22, 2003
Concentrations of serum total activin A and inhibin A in preterm and term labor patients: a cross-sectional studyMichael P Plevyak, Geralyn M Lambert-Messerlian, Antonio Farina, et al.
Pageof 5